Page last updated: 2024-11-08

opc 4392

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

OPC 4392: agonist of presynaptic dopamine D(2) receptor; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID163839
CHEMBL ID55171
SCHEMBL ID2424904
MeSH IDM0154026

Synonyms (19)

Synonym
gtpl268
opc-4392
PDSP2_000677
opc 4392
PDSP1_000687
111073-34-8
CHEMBL55171
L001306
bdbm82065
nsc_163839
cas_163839
7-[3-[4-(2,3-dimethylphenyl)piperazin-1-yl]propoxy]-1h-quinolin-2-one
2(1h)-quinolinone, 7-(3-(4-(2,3-dimethylphenyl)-1-piperazinyl)propoxy)-
7-(3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy)-2(1h)-quinolone
SCHEMBL2424904
2(1h)-quinolinone, 7-[3-[4-(2,3-dimethylphenyl)-1-piperazinyl]propoxy]-
7-{3-[4-(2,3-dimethylphenyl)piperazin-1-yl]propoxy}quinolin-2-ol
DTXSID40911984
Q27088206

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The severity of these symptoms increased dose-dependently, and the upper limit dosage of OPC was considered to be 5 mg for the healthy volunteers."( Phase 1 study of a new antipsychotic drug, OPC-4392.
Fukuyama, Y; Ishigooka, J; Ishii, Y; Miura, S; Murasaki, M; Takahashi, A, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID222072Effect on the time required for recovery from coma induced in mice by cerebral concussion (treated group);NT means not tested2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.
AID113719Inhibition of noradrenaline lethal effects in mice as alpha-1 induced adrenoceptor antagonist activity1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.
AID223176Effect on the sleeping time of mice before halothane load (control group)2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.
AID114076post-synaptic dopamine autoreceptor antagonist activity evaluated by inhibition of the apomorphine-induced stereotyped behavior in mice.1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.
AID113715Inhibition of the GBL-induced increase in DOPA accumulation in mice(DA auto receptor agonist activity)1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.
AID113544Induction of catalepsy in mice.1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.
AID223173Effect on the sleeping time of mice anesthetized with halothane (treated group)2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.
AID113714Inhibition of the APO-induced stereotyped behavior in mice.1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.
AID113717Inhibition of the GBL-induced increase in DOPA synthesis in mice.1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.
AID222071Effect on the time required for recovery from coma induced in mice by cerebral concussion (control group);NT means not tested2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.
AID234393ratio between ED50 values of DA receptor antagonist activity and catalepsy.1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.
AID204600Binding affinity for sigma receptors was evaluated by the inhibitory effect on [3H]DTG to rat whole brain membranes;NT means not tested.2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.
AID1345235Rat 5-HT7 receptor (5-Hydroxytryptamine receptors)1999Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Jun, Volume: 20, Issue:6
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.
AID1345154Rat 5-HT6 receptor (5-Hydroxytryptamine receptors)1999Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Jun, Volume: 20, Issue:6
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (37.50)18.7374
1990's6 (37.50)18.2507
2000's4 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.38 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (6.25%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]